Phreesia, Inc. — Cyborg Score 7/10

Strong
Healthcare Software-as-a-Service (SaaS) / Health IT

Strategic Profile

Phreesia's competitive advantage lies in its comprehensive end-to-end patient access and financial management capabilities, seamlessly integrated across multiple modalities including mobile apps, tablets (PhreesiaPads), and kiosks. The company's subscription-based model delivers recurring revenue while its payment processing services create additional revenue streams, positioning it as an essential operational partner for healthcare organizations seeking workflow efficiency and revenue optimization.

Cyborg Score Rationale

Phreesia demonstrates solid market positioning with recurring subscription revenue, significant scale (170M+ patient visits annually), and strong customer integration. However, the stock trades near 52-week lows with mixed analyst sentiment, and profitability remains challenged despite revenue growth, suggesting execution risks in the current market environment.

Top Insights

  • Handles approximately 1 in 7 U.S. patient visits (170M+ annually), demonstrating massive scale and market penetration across healthcare providers
  • Dual revenue model combining subscription services with payment processing creates multiple value streams and cross-sell opportunities
  • Recent acquisitions (QueueDr, Insignia Health) expand platform capabilities into appointment optimization and patient activation measurement
  • Platform integration complexity and switching costs create strong customer retention but also limit market expansion outside existing customer base

Named Competitors

  • Electronic Health Records (EHR) Platform — Dominant EHR platform with integrated patient access capabilities
  • Electronic Health Records (EHR) Platform — Large-scale EHR provider with patient engagement tools
  • Patient Scheduling & Access — Healthcare technology platform with patient access solutions

Recent Developments

  • (2021) Acquired QueueDr appointment management solution, now offered as Appointment Accelerator
  • (2021) Acquired Insignia Health for Patient Activation Measure licensing
  • (2024) Enabled 170 million patient visits representing 1 in 7 U.S. visits

Open the full interactive Phreesia, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →